ConductScience.org, home

Paper41347637

Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data.

Bracis C and 5 others. CPT Pharmacometrics Syst Pharmacol, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data. Papers, record 41347637. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41347637

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data.
PubMed
Journal
CPT Pharmacometrics Syst Pharmacol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-10-23
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bracis CChloehttps://orcid.org/0000-0003-4058-7638
2Taneja AAmithttps://orcid.org/0000-0003-3999-8405
3Lyauk YKYassine Kamalhttps://orcid.org/0000-0003-1349-2801
4Barcomb HHeather
5de la Peña AAmparohttps://orcid.org/0009-0009-6341-4933
6Cellière GGéraldinehttps://orcid.org/0009-0009-6904-5569

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Meta-Analysis as TopicMajor topic
Models, StatisticalMajor topic
Humans
Arthritis, Rheumatoid
Osteoarthritis
Antibodies, Monoclonal, Humanized
Naproxen
Longitudinal Studies
Drug Development

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133782057The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021https://conductscience.org/library/papers/33782057PubMed
226933516The Many Flavors of Model-Based Meta-Analysis: Part I-Introduction and Landmark Data.CPT Pharmacometrics Syst Pharmacol2016https://conductscience.org/library/papers/26933516PubMed
321618201Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.Arthritis Rheum2011https://conductscience.org/library/papers/21618201PubMed
422048227A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis.Clin Pharmacol Ther2011https://conductscience.org/library/papers/22048227PubMed
521088872The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.J Pharmacokinet Pharmacodyn2011https://conductscience.org/library/papers/21088872PubMed
622760002Longitudinal model-based meta-analysis in rheumatoid arthritis: an application toward model-based drug development.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22760002PubMed
734534661Epidemiology of osteoarthritis.Osteoarthritis Cartilage2022https://conductscience.org/library/papers/34534661PubMed
822089340Model-based meta-analysis for comparative efficacy and safety: application in drug development and beyond.Clin Pharmacol Ther2011https://conductscience.org/library/papers/22089340PubMed
938724461Application and Quality of Model-Based Meta-Analysis in Pharmaceutical Research: A Systematic Cross-Sectional Analysis and Practical Considerations.Clin Pharmacol Ther2024https://conductscience.org/library/papers/38724461PubMed
1022910485Model-based meta-analysis: an important tool for making quantitative decisions during drug development.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22910485PubMed
1141347637Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41347637PubMed
127779114American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.Arthritis Rheum1995https://conductscience.org/library/papers/7779114PubMed
1318055472
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.
Ann Rheum Dis2008https://conductscience.org/library/papers/18055472PubMed
1412528101Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.Arthritis Rheum2003https://conductscience.org/library/papers/12528101PubMed
1516052582Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.Arthritis Rheum2005https://conductscience.org/library/papers/16052582PubMed
1635174432Applications of Model-Based Meta-Analysis in Drug Development.Pharm Res2022https://conductscience.org/library/papers/35174432PubMed
1736631827Concept and application of the probability of pharmacological success (PoPS) as a decision tool in drug development: a position paper.J Transl Med2023https://conductscience.org/library/papers/36631827PubMed
1815146409
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Arthritis Rheum2004https://conductscience.org/library/papers/15146409PubMed
1930993679Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence.Clin Pharmacol Ther2019https://conductscience.org/library/papers/30993679PubMed
2020358280Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation.J Pharmacokinet Pharmacodyn2010https://conductscience.org/library/papers/20358280PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42438069Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42438069PubMed
41867226When Survival Improves But Quality of Life Does Not: A Model-Based Meta-Analysis of Immune Checkpoint Inhibitors.medRxiv2026https://conductscience.org/library/papers/41867226PubMed
41754991Systematic Review and Model-Based Meta-Analysis of Targeted Drugs for Systemic Sclerosis.Pharmaceutics2026https://conductscience.org/library/papers/41754991PubMed
41347637Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41347637PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41347637

GET https://conductscience.org/api/papers/v1/41347637/references?page=2